Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.0
(1.17%)
CNY 13.0
(1.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 714.1 Million CNY | 101.21% |
| 2022 | 354.9 Million CNY | 129.76% |
| 2021 | 154.46 Million CNY | 2.98% |
| 2020 | 150 Million CNY | 114.08% |
| 2019 | 70.06 Million CNY | -29.93% |
| 2018 | 100 Million CNY | 16.28% |
| 2017 | 86 Million CNY | -66.21% |
| 2016 | 254.5 Million CNY | -3.78% |
| 2015 | 264.5 Million CNY | 5777.78% |
| 2014 | 4.5 Million CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 27.42 Million CNY | -45.16% |
| 2011 | 50 Million CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 18 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 607.09 Million CNY | -14.99% |
| 2024 Q3 | 385.09 Million CNY | -27.78% |
| 2024 Q2 | 534.44 Million CNY | -11.97% |
| 2023 Q4 | 714.1 Million CNY | 103.4% |
| 2023 Q3 | 351.09 Million CNY | 4.42% |
| 2023 FY | 714.1 Million CNY | 101.21% |
| 2023 Q1 | 353.86 Million CNY | -0.29% |
| 2023 Q2 | 336.24 Million CNY | -4.98% |
| 2022 FY | 354.9 Million CNY | 129.76% |
| 2022 Q1 | 153.65 Million CNY | -0.52% |
| 2022 Q4 | 354.9 Million CNY | 20.19% |
| 2022 Q3 | 295.27 Million CNY | 16.66% |
| 2022 Q2 | 253.09 Million CNY | 64.71% |
| 2021 FY | 154.46 Million CNY | 2.98% |
| 2021 Q1 | 150 Million CNY | 0.0% |
| 2021 Q2 | 180 Million CNY | 20.0% |
| 2021 Q3 | 185.26 Million CNY | 2.92% |
| 2021 Q4 | 154.46 Million CNY | -16.62% |
| 2020 Q2 | 200.07 Million CNY | 185.54% |
| 2020 Q3 | 200 Million CNY | -0.04% |
| 2020 FY | 150 Million CNY | 114.08% |
| 2020 Q1 | 70.06 Million CNY | 0.0% |
| 2020 Q4 | 150 Million CNY | -25.0% |
| 2019 FY | 70.06 Million CNY | -29.93% |
| 2019 Q4 | 70.06 Million CNY | -46.1% |
| 2019 Q3 | 130 Million CNY | 0.0% |
| 2019 Q2 | 130 Million CNY | 30.0% |
| 2019 Q1 | 100 Million CNY | 0.0% |
| 2018 Q1 | 150 Million CNY | 74.42% |
| 2018 FY | 100 Million CNY | 16.28% |
| 2018 Q4 | 100 Million CNY | -29.82% |
| 2018 Q3 | 142.5 Million CNY | 0.0% |
| 2018 Q2 | 142.5 Million CNY | -5.0% |
| 2017 Q3 | 154.5 Million CNY | 0.0% |
| 2017 Q4 | 86 Million CNY | -44.34% |
| 2017 FY | 86 Million CNY | -66.21% |
| 2017 Q1 | 154.5 Million CNY | -39.29% |
| 2017 Q2 | 154.5 Million CNY | 0.0% |
| 2016 Q1 | 304.5 Million CNY | 15.12% |
| 2016 FY | 254.5 Million CNY | -3.78% |
| 2016 Q4 | 254.5 Million CNY | -8.94% |
| 2016 Q3 | 279.5 Million CNY | 0.0% |
| 2016 Q2 | 279.5 Million CNY | -8.21% |
| 2015 Q4 | 264.5 Million CNY | 5266.04% |
| 2015 Q2 | 5.65 Million CNY | 8.21% |
| 2015 Q1 | 5.22 Million CNY | 16.09% |
| 2015 FY | 264.5 Million CNY | 5777.78% |
| 2015 Q3 | 4.92 Million CNY | -12.81% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 4.5 Million CNY | 0.0% |
| 2014 Q4 | 4.5 Million CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2012 FY | 27.42 Million CNY | -45.16% |
| 2011 FY | 50 Million CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2009 FY | 18 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 4.29 Billion CNY | 83.361% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.34 Billion CNY | 78.662% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 37.118% |
| Medicalsystem Biotechnology Co., Ltd. | 108.17 Million CNY | -560.164% |
| Maccura Biotechnology Co.Ltd | 665.16 Million CNY | -7.358% |
| Guangzhou Wondfo Biotech Co.,Ltd | 599.53 Million CNY | -19.11% |
| Guangdong Hybribio Biotech Co.,Ltd. | 56.65 Million CNY | -1160.507% |
| BGI Genomics Co., Ltd. | 1.09 Billion CNY | 34.868% |
| Amoy Diagnostics Co., Ltd. | 108.34 Million CNY | -559.098% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 374.62 Million CNY | -90.621% |